J9031 HCPCS Level II code: Bcg (intravesical) per instillation
CMS terminated J9031: its last date of service was Jun 30, 2019. It stays here for looking up older claims; newer services need a current code.
Official description
J9031Bcg (intravesical) per instillation
Short description: Bcg live intravesical vac
HCPCS · United States
Medicare details
The indicators CMS publishes with J9031 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1991
- Terminated after
- Jun 30, 2019
Where J9031 sits
- 1J codesDrugs administered other than orally
- 2Terminated J9031Bcg (intravesical) per instillation
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J9031 still valid?
No. CMS terminated J9031; its last date of service was Jun 30, 2019. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J9031?
CMS lists J9031’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9031
All J codesJ9025Injection, azacitidine, 1 mgJ9026Injection, tarlatamab-dlle, 1 mgJ9027Injection, clofarabine, 1 mgJ9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgramJ9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic doseJ9030Bcg live intravesical instillation, 1 mgJ9032Injection, belinostat, 10 mgJ9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mgJ9034Injection, bendamustine hcl (bendeka), 1 mgJ9035Injection, bevacizumab, 10 mgJ9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mgJ9037Injection, belantamab mafodotin-blmf, 0.5 mg